최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Vaccine, v.19 no.15/16, 2001년, pp.2012 - 2019
Vassilev, Ventzislav B. (Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0905, USA) , Gil, Laura H.V.G. (Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0905, USA) , Donis, Ruben O. (Corresponding author. Tel.: +1-402-4726063)
AbstractInfectious transcripts from the full-length infectious clone of the NADL strain of bovine viral diarrhea virus (BVDV) were used to vaccinate cattle and sheep against BVDV. In vitro synthesized RNA delivered by microparticle bombardment with a Helios Gene Gun initiated replication of BVDV and...
Mol. Biotechnol. Ada 8 2 123 1997 10.1007/BF02752256 Overview of vaccines
Biologicals Wood 25 1 3 1997 10.1006/biol.1997.0055 Laboratory tests for live attenuated poliovirus vaccines
Proc. Natl. Acad. Sci. USA Fynan 90 24 11478 1993 10.1073/pnas.90.24.11478 DNA vaccines: protective immunizations by parenteral, mucosal, and Gene-Gun inoculations
J. Exp. Med. Akbari 189 1 169 1999 10.1084/jem.189.1.169 DNA vaccination: transfection and activation of dendritic cells as key events for immunity
Antiviral Res. Ghiasi 28 2 147 1995 10.1016/0166-3542(95)00045-N Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge
J. Virol. Hariharan 72 2 950 1998 10.1128/JVI.72.2.950-958.1998 DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector
J. Immunol. Manickan 155 1 259 1995 10.4049/jimmunol.155.1.259 Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes
Pharm. Res. Gregoriadis 15 5 661 1998 10.1023/A:1011950415325 Genetic vaccines: strategies for optimization
Crit. Rev. Immunol. Manickan 17 2 139 1997 10.1615/CritRevImmunol.v17.i2.20 DNA vaccines - a modern gimmick or a boon to vaccinology
Clin. Microbiol. Rev. Vogel 8 3 406 1995 10.1128/CMR.8.3.406 Nucleic acid vaccines
Vaccine Lunn 17 18 2245 1999 10.1016/S0264-410X(98)00496-4 Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene
Nat. Med. Mandl 4 12 1438 1998 10.1038/4031 In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
DTW Dtsch Tierarztl Wochenschr Kreeft 97 2 63 1990 Attempts to characterize bovine viral diarrhea virus isolated from cattle after immunization with a contaminated vaccine
Lohr CH, Evermann JF, Ward AC. Investigation of dams and their offspring inoculated with a vaccine contaminated by bovine viral diarrhea virus. Vet Med/Sm An Clinician 1983;1263-266.
J. Virol. Vassilev 71 1 471 1997 10.1128/JVI.71.1.471-478.1997 Authentic and chimeric full-length genomic cDNA clones of bovine viral diarrhea virus that yield infectious transcripts
J. Gen. Virol. Donis 68 Pt. 6 1607 1987 10.1099/0022-1317-68-6-1607 Glycoproteins of viral diarrhoea-mucosal disease virus in infected bovine cells
Virus Res. Vassilev 69 2 95 2000 10.1016/S0168-1702(00)00176-3 Bovine viral diarrhea virus induced apoptosis correlates with increased intracellular viral RNA accumulation
Virology Ridpath 212 1 259 1995 10.1006/viro.1995.1480 Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV
Anal. Biochem. Le Pecq 17 1 100 1966 10.1016/0003-2697(66)90012-1 A new fluorometric method for RNA and DNA determination
Gene Ther. Qiu 3 3 262 1996 Gene Gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization
J. Virol. Corapi 62 8 2823 1988 10.1128/JVI.62.8.2823-2827.1988 Monoclonal antibody analyses of cytopathic and noncytopathic viruses from fatal bovine viral diarrhea virus infections
J. Virol. Behrens 72 3 2364 1998 10.1128/JVI.72.3.2364-2372.1998 Characterization of an autonomous subgenomic pestivirus RNA replicon
Vet. Microbiol. Bruschke 50 1-2 33 1996 10.1016/0378-1135(96)00024-7 Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies
Vaccine Bruschke 15 17-18 1940 1997 10.1016/S0264-410X(97)00125-4 A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge
Vet. Microbiol. Paton 64 2-3 185 1999 10.1016/S0378-1135(98)00269-7 Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes
J. Vet. Diagn. Invest. Renshaw 12 2 184 2000 10.1177/104063870001200219 Comparison of virus isolation and reverse transcription polymerase chain reaction assay for detection of bovine viral diarrhea virus in bulk milk tank samples
Am. J. Vet. Res. Bolin 56 6 755 1995 Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves
J. Gen. Virol. Harpin 80 Pt. 12 3137 1999 10.1099/0022-1317-80-12-3137 Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2
Virology Braun 265 1 46 1999 10.1006/viro.1999.0032 Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1
J. Infect. Dis. Boyer 181 2 476 2000 10.1086/315229 Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines
Science Barouch 290 5491 486 2000 10.1126/science.290.5491.486 Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination (in process citation)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.